Cyclooxygenase-2 silencing for the treatment of colitis: a combined in vivo strategy based on RNA interference and engineered Escherichia coli.

Spisni, Enzo

Cyclooxygenase-2 silencing for the treatment of colitis: a combined in vivo strategy based on RNA interference and engineered Escherichia coli. [electronic resource] - Molecular therapy : the journal of the American Society of Gene Therapy Feb 2015 - 278-89 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1525-0024

10.1038/mt.2014.222 doi


Animals
Colitis--chemically induced
Cyclooxygenase 2--genetics
Disease Models, Animal
Down-Regulation
Escherichia coli--genetics
Gastrointestinal Microbiome
Gene Expression
Gene Silencing
Gene Transfer Techniques
Genetic Therapy
Intestinal Mucosa--metabolism
Mice
RNA Interference
RNA, Messenger--genetics
RNA, Small Interfering--genetics